1DROP’s goal is to improve patient lives by enabling personalized healthcare through non-invasive diagnostic tests providing actionable health information that is accessible to everyone at any time. 1DROP facilitates the early detection, prevention and management of disease and empowers people to live better lives. 1DROP highly values collaboration, prioritizing the needs of customers and rapidly delivering solutions. 1DROP’s innovative diagnostic solutions for multiplexed assays of proteins, nucleic acids and peptides serve as tools for the development of new therapies and drugs, disease research, and clinical diagnostics tests. The company is based in Neuchatel, Switzerland and Boston, United States and is supported by some of the most highly regarded experts in the field of biosensors.